ProShare Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$419K Buy
+6,439
New +$292K ﹤0.01% 1131
2025
Q3
– Sell
-11,179
Closed -$218K – 2026
2025
Q2
$218K Buy
11,179
+47
+0.4% +$835 ﹤0.01% 1667
2025
Q1
$198K Sell
11,132
-3,108
-22% -$66.9K ﹤0.01% 1693
2024
Q4
$305K Buy
14,240
+4,685
+49% +$114K ﹤0.01% 1619
2024
Q3
$298K Buy
+9,555
New +$238K ﹤0.01% 1467
2022
Q2
– Sell
-9,490
Closed -$351K – 1839
2022
Q1
$351K Sell
9,490
-1,563
-14% -$60.9K ﹤0.01% 1519
2021
Q4
$503K Buy
11,053
+4,569
+70% +$238K ﹤0.01% 1437
2021
Q3
$411K Sell
6,484
-6,506
-50% -$495K ﹤0.01% 1328
2021
Q2
$1.19M Sell
12,990
-440
-3% -$35K ﹤0.01% 932
2021
Q1
$914K Buy
13,430
+2,824
+27% +$219K ﹤0.01% 1044
2020
Q4
$768K Buy
10,606
+4,737
+81% +$274K ﹤0.01% 1006
2020
Q3
$223K Buy
5,869
+50
+0.9% +$1.69K ﹤0.01% 1359
2020
Q2
$206K Buy
+5,819
New +$166K ﹤0.01% 1441

Other funds holding CDNA

ProShare Advisors's CDNA Position: Q3 2026 in Review

ProShare Advisors opened a new position in CareDx (CDNA) in Q3 2026: 6,439 shares worth $419K. The stake represents ﹤0.01% of the portfolio and ranks #1131 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in CDNA as recently as Q2 2025.

ProShare Advisors first reported a position in CDNA in Q2 2020 and has held it in 13 quarters since. The position peaked at $1.19M in Q2 2021. 119 funds tracked by Wall St. Rank hold CDNA as of Q3 2026.

  • ProShare Advisors held 6,439 shares of CareDx worth $419K as of Q3 2026.
  • CareDx was a new ProShare Advisors position in Q3 2026.
  • CareDx made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1131 holding.
  • ProShare Advisors first reported a position in CareDx in Q2 2020 and has held it in 13 quarters since.
  • ProShare Advisors's CareDx position peaked at $1.19M in Q2 2021.
  • 119 funds tracked by Wall St. Rank held CareDx as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.